| Standard lipoaspirate | ASC-enriched lipoaspirate | Statistical significance | ASC-enriched lipoaspirate technique |  | |
---|---|---|---|---|---|---|
Cytori | Lipokit | Fastem | ||||
Clinical features | Â | Â | Â | Â | Â | Â |
n (%) | 16 (44.4%) | 20 (55%) | Â | 9 (25%) | 5 (13.8%) | 6 (16.7%) |
Age (years) | 49.5 (21 to 71) | 48 (19 to 74) | P = 0.8370 | 46 (41 to 70) | 52 (41 to 57) | 52 (19 to 74) |
BMI (kg/m2) | 22.35 (19.36 to 30.3) | 21.4 (19.8 to 32.8) | P = 0.7520 | 21.30 (20.58 to 30.5) | 22.19 (20 to 32.8) | 21.20 (19.8 to 24.4) |
Co-morbidities | 0 (0.0%) | 2 (10.0%) | P = 0.4921 | 1 (11.1%) | 1 (20.0%) | 0 (0.0%) |
Previous surgical procedure | ||||||
Mastectomy | 14 (87.50%) | 16 (80.00%) | P = 0.6722 | 8 (89%) | 5 (100%) | 3 (50%) |
Quadrantectomy | 1 (6.25%) | 2 (10.00%) | P = 1.0000 | 1 (11.1%) | 0 (0.00%) | 1 (16.7%) |
None (congenital malformation) | 1 (6.25%) | 2 (10.00%) | P = 1.0000 | 0 (0.00%) | 0 (0.00%) | 2 (33.3%) |
Donor area | Â | Â | Â | Â | Â | Â |
Abdomen | 5 (31.25%) | 1 (5.00%) | P = 0.0689 | 0 (0.00%) | 0 (0.00%) | 1 (16.7%) |
Hips | 7 (43.75%) | 7 (35.00%) | chi-q = 0.5926 | 3 (22.2%) | 3 (60%) | 1 (16.7%) |
Trochanteric region | 2 (12.50%) | 2 (10.00%) | P = 1.0000 | 1 (11.1%) | 0 (0.00%) | 1 (16.7%) |
Abdomen and hips | 2 (12.50%) | 4 (20%) | P = 0.6722 | 1 (11.1%) | 2 (40%) | 1 (16.7%) |
Hips and trochanteric region | 0 (0.00%) | 4 (20%) | P = 0.1131 | 3 (22.2%) | 0 (0.00%) | 1 (16.7%) |
Abdomen and trochanteric region | 0 (0.00%) | 1 (5.00%) | P = 1.0000 | 0 (0.00%) | 0 (0.00%) | 1 (16.7%) |
Abdomen. hips and trochanteric region | 0 (0.00%) | 1 (5.00%) | P = 1.0000 | 1 (11.1%) | 0 (0.00%) | 0 (0.00%) |
Amount of solution infiltrated (cm3) | 95 (54 to 160) | 143 (60 to 230) | P = 0.0540 | 158 (75 to 230) | 145 (60 to 175) | 85 (75 to 165) |
Adjuvant therapies | ||||||
None | 6 (37.5%) | 11 (55%) | P = 0.3351 | 5 (55.6%) | 2 (40%) | 4 (66.7%) |
RT | 1 (6.25%) | 3 (15.00%) | P = 0.6129 | 1 (11.1%) | 1 (20%) | 1 (16.7%) |
CT | 7 (43.75%) | 3 (15.00%) | P = 0.0732 | 1 (11.1%) | 2 (40%) | 0 (0.00%) |
RT and CT | 2 (12.50%) | 3 (15.00%) | P = 1.0000 | 2 (22.2%) | 0 (0.00%) | 1 (16.7%) |
Hormonal therapies | 7 (43.75%) | 12 (60.00%) | chi-q = 0.3318 | 6 (67%) | 4 (80%) | 2 (33.3%) |